肝损伤
生物标志物
脂肪肝
疾病
药品
肝病
重症监护医学
临床试验
脂肪性肝炎
医学
生物信息学
生物
药理学
内科学
生物化学
化学
作者
Simran Thakur,Vishal Kumar,Rina Das,Vishal Sharma,Dinesh Kumar Mehta
标识
DOI:10.1016/j.curtheres.2024.100737
摘要
Hepatotoxicity is the foremost issue for clinicians and the primary reason for pharmaceutical product recalls. A biomarker is a measurable and quantifiable attribute used to evaluate the efficacy of a treatment or to diagnose a disease. There are various biomarkers which are used for the detection of liver disease and the intent of liver damage.
科研通智能强力驱动
Strongly Powered by AbleSci AI